BOTULINUM TOXIN TREATMENT AND NEUROMODULATION FOR OVERACTIVE BLADDER

被引：1
|
作者：
Akman, R. Yavuz [1 ]
机构：
[1] Baskent Univ, Baskent Univ Istanbul Hastanesi, Tip Fak, Urol Anabilim Dali, TR-34662 Istanbul, Turkey
来源：
TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2013年 / 10卷 / 01期
关键词：
botulinum toxin; neuromodulation; overactive bladder;
D O I：
10.5505/tjod.2013.32815
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
The overactive bladder (OAB) is a symptom complex characterized by urgency with/without urge incontinence, and often associated with frequency and nocturia. First-line therapy for OAB includes behavioral therapies and anticholinergic drugs. Although a large number of patients respond to conservative or pharmacological therapy or a combination of the two, some patients are refractory and require additional options for intervention. Botulinum toxin therapy and neuromodulation are frequently used treatment options in refractory OAB patients.
引用
收藏
页码：9 / 15
页数：7
相关论文
共 50 条
  • [41] Prospective study of the clinical and urodynamic results of intradetrusor botulinum toxin injections for the treatment of neurogenic overactive bladder
    Bentaleb, Y.
    Castel-Lacanal, E.
    Sallusto, F.
    De Boissezon, X.
    Malavaud, B.
    Marque, P.
    Rischmann, P.
    Game, X.
    PROGRES EN UROLOGIE, 2008, 18 (07): : 449 - 455
  • [42] Neurotoxin Versus Neuromodulation for the Treatment of Refractory Overactive Bladder Syndrome
    Chancellor, Michael B.
    Costa, Frank
    Kuo, Hann-Chorng
    TZU CHI MEDICAL JOURNAL, 2008, 20 (02): : 109 - 111
  • [43] Paraplegia as a complication of intravesical Botulinum toxin A (Dysport (R)) injection for overactive bladder
    Awsare, Ninaad S.
    Jones, David R.
    JOURNAL OF CLINICAL UROLOGY, 2009, 2 (03) : 127 - 128
  • [44] Correction of overactive bladder with botulinum toxin type A (BTX-A)
    Grishin, Andrey
    Spaska, Anastasiya
    Kayumova, Lyailya
    TOXICON, 2021, 200 : 96 - 101
  • [45] Botulinum toxin for the treatment of overactive bladder - An overview [Botulinumtoxin in der therapie der überaktiven blase - ein Überblick]
    Seif C.
    Boy S.
    Wefer B.
    Dmochowski R.
    Braun P.M.
    Jünemann K.-P.
    Der Urologe, 2008, 47 (1): : 46 - 53
  • [46] Mirabegron in Overactive Bladder and Its Role in Exit Strategy After Botulinum Toxin Treatment in Children
    Tan, Denise Jia Yun
    Weninger, Julia
    Goyal, Anju
    FRONTIERS IN PEDIATRICS, 2022, 9
  • [47] Sacral neuromodulation and Botulinum toxin A for refractory idiopathic overactive bladder: a cost-utility analysis in the perspective of Italian Healthcare System
    Bertapelle, Maria Paola
    Vottero, Mario
    Del Popolo, Giulio
    Mencarini, Marco
    Ostardo, Edoardo
    Spinelli, Michele
    Giannantoni, Antonella
    D'Ausilio, Anna
    WORLD JOURNAL OF UROLOGY, 2015, 33 (08) : 1109 - 1117
  • [48] Sacral neuromodulation and Botulinum toxin A for refractory idiopathic overactive bladder: a cost-utility analysis in the perspective of Italian Healthcare System
    Maria Paola Bertapelle
    Mario Vottero
    Giulio Del Popolo
    Marco Mencarini
    Edoardo Ostardo
    Michele Spinelli
    Antonella Giannantoni
    Anna D’Ausilio
    World Journal of Urology, 2015, 33 : 1109 - 1117
  • [49] Long-term outcome of the use of intravesical botulinum toxin for the treatment of overactive bladder (OAB)
    Mohee, Amar
    Khan, Ayisha
    Harris, Neil
    Eardley, Ian
    BJU INTERNATIONAL, 2013, 111 (01) : 106 - 113
  • [50] Medium- to long-term outcomes of botulinum toxin A for idiopathic overactive bladder
    Eldred-Evans, David
    Sahai, Arun
    THERAPEUTIC ADVANCES IN UROLOGY, 2017, 9 (01) : 3 - 10
12345